
Sign up to save your podcasts
Or


Luca Quagliata, PhD, global head of medical affairs for clinical NGS and oncology at Thermo Fisher Scientific, shares how his career has been intertwined with precision medicine, beginning with his time as a student in Italy during the early 2000s. Quagliata examines the significance of genomic profiling within the cancer care continuum, outlining the essential steps and touchpoints necessary to ensure the accessibility of personalized oncology treatment for all individuals.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.
7Q4XKpRvPIvPZPkK6RbZ
Produced by Bill Levine
Hosted by Jonathan D. Grinstein, PhD
Music provided by Artem Hramushkin
Audio mixed and mastered by Jason Mack
Hosted on Acast. See acast.com/privacy for more information.
By Inside Precision Medicine5
44 ratings
Luca Quagliata, PhD, global head of medical affairs for clinical NGS and oncology at Thermo Fisher Scientific, shares how his career has been intertwined with precision medicine, beginning with his time as a student in Italy during the early 2000s. Quagliata examines the significance of genomic profiling within the cancer care continuum, outlining the essential steps and touchpoints necessary to ensure the accessibility of personalized oncology treatment for all individuals.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.
7Q4XKpRvPIvPZPkK6RbZ
Produced by Bill Levine
Hosted by Jonathan D. Grinstein, PhD
Music provided by Artem Hramushkin
Audio mixed and mastered by Jason Mack
Hosted on Acast. See acast.com/privacy for more information.

754 Listeners

113,483 Listeners

3,334 Listeners

2,301 Listeners

5 Listeners